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We describe the growth of a primary left atrial myxoma over a period of approximately 27 months, review the literature on
the growth rate of primary myxoma and discuss the value of echocardiography compared to CT scan and MRI in the
diagnosis of intracardiac tumuors.
Introduction
The growth rate of primary cardiac myxoma can rarely be
established because of the lack of specific symptoms
before the tumour has reached a certain size'1'.
We report a case of left atrial myxoma discovered 27
months after an echocardiogram had showed normal
cardiac chambers; we discuss the growth rate of this
benign tumour and review the literature on the growth
rate of primary myxoma.
A woman, born in 1918, was hospitalized in February
1992 after several falls without loss of consciousness
during the preceding days. She had been treated for heart
failure and hypertension in December 1989. A transthor-
acic echocardiogram performed at that time had shown
mitral valve prolapse and moderate mitral regurgitation,
confirming the auscultation of a decreased first heart
sound with a holosystolic murmur, maximal at the heart
apex (Fig. l(a)).
On admission, she was sub-febrile. Her blood pressure
was 150/190 mmHg and pulse regular at 100 beats. min"1.
The first heart sound was louder than the second, and a
systolic murmur was heard along the right sternal border;
there was no opening snap or diastolic rumble. There were
no signs of right heart failure. The respiratory rate was
20 min ' and there were slight crackles at both lung bases.
Because the cardiac ausculation was different from that
described in December 1989, a transthoracic echocardio-
gram was performed. This second echocardiogram
showed a left atrial myxoma prolapsing through the mitral
valve during diastole and tricuspid regurgitation (Fig.
l(b)). On the following day, the myxoma attached at the
fossa ovalis was resected without complication. The
myxoma weighed 42 g and measured 4-5 x 2-9 x 3-9 cm.
Discussion
Histologically, myxomas consist of an acid muco-
polysacharide matrix containing polygonal cells and
occasional blood vessels. Although recurrent myxomas
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have been described after resection, such occurrences
have been explained by incomplete resection or multifocal
growth, and the malignant nature of the tumour has never
been ascertained'2'. The Mayo clinic group'3' described the
cytogenetic characteristics of myxomas and demonstrated
chromosomally abnormal clones and non-random telo-
metric translocations without finding criteria for a true
neoplastic disease.
Few reports of growth of primary myxoma have been
published. Marinissen et a/.'4' reported the resection of a
left atrial myxoma of 6 x4cm 18 months after the patient
had had an aortocoronary bypass graft and a normal M-
mode echocardiogram of the left atrium. Roudaut et a/.'5'
reported the resection of a myxoma of approximately
5-5 x 4 cm, which had grown over 7 months following a
control angiography after a coronary bypass operation.
In our patient, the growth rate of the primary myxoma
can be only approximate as growth may have started at
any point between the first and the second transthoracic
echocardiogram. If we take 27 months as the maximum
possible period of growth, the growth rate compares with
the figure cited for recurrent myxomas'61, i.e. 1 -5 g per
month. The fact that the growth rate of primary myxoma
is the same as that in those that recur would support
further the non-malignant nature of the tumour.
Transthoracic echocardiography is the preferred diag-
nostic tool for the detection of intracardiac tumours
because of good contrast between tumour and echo-
lucent chamber cavity and its ease of obtention; the value
of this technique has improved with the transoesophageal
approach which provides higher quality images especially
of the right atrium and interatrial septum'71. Other
techniques used to detect intracardiac tumours, such
as computed tomography (CT)'8', cine-computed-
tomography or magnetic resonance imaging (MRI)'9' are
more useful in that they provide information on the site of
attachement of the tumour to the wall of the cardiac
chamber, or to differentiate a tumour from a thrombus
by the tissue characterization'10'. Compared to CT, MRI
has the ability to generate images in multiple planes, a
feature that will also be available soon with multiplane
transoesophageal echocardiography. This last technique
will have the advantage of its easy availability and lower
cost, compared to MRI, but will still lack tissue
characterization.
0I95-668X 93 081146 + 02 $08.00 0 © 1993 The European Society of Cardiology
Growth rate in primary myxoma 1147
(a)
Figure 1 (a) Transthoracic echocardiogram in the left pastemal view LA = left atrium;
LV = left ventricle; AO = aorta; RV = right ventricle, (b) Transthoracic echocardiogram in
the left parasternal view. Abbreviations are the same as in Fig. 1 (a). My = myxoma.
With the increased use of transthoracic and transoeso-
phageal echocardiography, and other cardiac imaging
techniques more myxomas will be discovered on repeat
examination, allowing a more accute estimation of their
growth.
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